PURPOSE: To review the ability of current imaging technologies to provide estimates of rates of structural change in glaucoma patients. PATIENTS AND METHODS: Review of literature. RESULTS: Imaging technologies, such as confocal scanning laser ophthalmoscopy (CSLO), scanning laser polarimetry (SLP), and optical coherence tomography (OCT), provide quantifiable and reproducible measurements of the optic disc and parapapillary retinal nerve fibre layer (RNFL). Rates of change as quantified by the rim area (RA) (for CSLO) and RNFL thickness (for SLP and OCT) are related to glaucoma progression as detected by conventional methods (eg, visual fields and optic disc photography). Evidence shows that rates of RNFL and RA loss are significantly faster in progressing compared with non-progressing glaucoma patients. CONCLUSION: Measurements of rates of optic disc and RNFL change are becoming increasingly precise and individualized. Currently available imaging technologies have the ability to detect and quantify progression in glaucoma, and their measurements may be suitable end points in glaucoma clinical trials.
PURPOSE: To review the ability of current imaging technologies to provide estimates of rates of structural change in glaucomapatients. PATIENTS AND METHODS: Review of literature. RESULTS: Imaging technologies, such as confocal scanning laser ophthalmoscopy (CSLO), scanning laser polarimetry (SLP), and optical coherence tomography (OCT), provide quantifiable and reproducible measurements of the optic disc and parapapillary retinal nerve fibre layer (RNFL). Rates of change as quantified by the rim area (RA) (for CSLO) and RNFL thickness (for SLP and OCT) are related to glaucoma progression as detected by conventional methods (eg, visual fields and optic disc photography). Evidence shows that rates of RNFL and RA loss are significantly faster in progressing compared with non-progressing glaucomapatients. CONCLUSION: Measurements of rates of optic disc and RNFL change are becoming increasingly precise and individualized. Currently available imaging technologies have the ability to detect and quantify progression in glaucoma, and their measurements may be suitable end points in glaucoma clinical trials.
Authors: Linda M Zangwill; Robert N Weinreb; Julia A Beiser; Charles C Berry; George A Cioffi; Anne L Coleman; Gary Trick; Jeffrey M Liebmann; James D Brandt; Jody R Piltz-Seymour; Keri A Dirkes; Suzanne Vega; Michael A Kass; Mae O Gordon Journal: Arch Ophthalmol Date: 2005-09
Authors: Maciej Wojtkowski; Vivek Srinivasan; James G Fujimoto; Tony Ko; Joel S Schuman; Andrzej Kowalczyk; Jay S Duker Journal: Ophthalmology Date: 2005-10 Impact factor: 12.079
Authors: Nicholas G Strouthidis; Andrew Scott; Neena M Peter; David F Garway-Heath Journal: Invest Ophthalmol Vis Sci Date: 2006-07 Impact factor: 4.799
Authors: C Bowd; L M Zangwill; C C Berry; E Z Blumenthal; C Vasile; C Sanchez-Galeana; C F Bosworth; P A Sample; R N Weinreb Journal: Invest Ophthalmol Vis Sci Date: 2001-08 Impact factor: 4.799
Authors: Gadi Wollstein; Joel S Schuman; Lori L Price; Ali Aydin; Paul C Stark; Ellen Hertzmark; Edward Lai; Hiroshi Ishikawa; Cynthia Mattox; James G Fujimoto; Lelia A Paunescu Journal: Arch Ophthalmol Date: 2005-04
Authors: Andrew J Patterson; David F Garway-Heath; Nicholas G Strouthidis; David P Crabb Journal: Invest Ophthalmol Vis Sci Date: 2005-05 Impact factor: 4.799
Authors: Kaweh Mansouri; Felipe A Medeiros; Nicholas Marchase; Andrew J Tatham; Daniel Auerbach; Robert N Weinreb Journal: Ophthalmology Date: 2013-09-08 Impact factor: 12.079
Authors: Felipe A Medeiros; Linda M Zangwill; Christopher Bowd; Kaweh Mansouri; Robert N Weinreb Journal: Invest Ophthalmol Vis Sci Date: 2012-10-05 Impact factor: 4.799
Authors: Kaweh Mansouri; Mauro T Leite; Robert N Weinreb; Ali Tafreshi; Linda M Zangwill; Felipe A Medeiros Journal: Am J Ophthalmol Date: 2011-10-21 Impact factor: 5.258
Authors: Andrew J Tatham; Erwin R Boer; Peter N Rosen; Mauro Della Penna; Daniel Meira-Freitas; Robert N Weinreb; Linda M Zangwill; Felipe A Medeiros Journal: Am J Ophthalmol Date: 2014-07-25 Impact factor: 5.258
Authors: Joseph A Majdi; Haohua Qian; Yichao Li; Robert J Langsner; Katherine I Shea; Anant Agrawal; Daniel X Hammer; Joseph P Hanig; Ethan D Cohen Journal: Invest Ophthalmol Vis Sci Date: 2014-12-18 Impact factor: 4.799
Authors: Mitra Sehi; Xinbo Zhang; David S Greenfield; Yunsuk Chung; Gadi Wollstein; Brian A Francis; Joel S Schuman; Rohit Varma; David Huang Journal: Am J Ophthalmol Date: 2012-10-01 Impact factor: 5.258
Authors: Linda M Zangwill; Sonia Jain; Keri Dirkes; Feng He; Felipe A Medeiros; Gary L Trick; James D Brandt; George A Cioffi; Anne L Coleman; Jeffrey M Liebmann; Jody R Piltz-Seymour; Mae O Gordon; Michael A Kass; Robert N Weinreb Journal: Am J Ophthalmol Date: 2013-03-14 Impact factor: 5.258